Literature DB >> 3878751

Influence of TPA (12-O-tetradodecanoyl-phorbol-13-acetate) on human B lymphocyte function.

F Falcioni, A Rautmann, P A Berg, W L Gross.   

Abstract

The effect of the tumour-promoting agent TPA (12-0-tetra-dodecanoyl-phorbol-13-acetate) on the proliferation and Ig secretion response of blood and tonsil lymphocytes was investigated and compared to that of the T-cell-dependent polyclonal activators pokeweed mitogen (PWM) and group A streptococcal cell membranes (A-ScM) or the T-cell-independent B cell mitogen Staphylococcus aureus Cowan I (SAC) and a T-cell-independent B cell activator Klebsiella pneumoniae (Klebs M). In blood mononuclear cells (MNC), a rather weak, monocyte-dependent DNA synthetic response was observed after exposure to TPA, in comparison to PWM, A-ScM or SAC. Whereas highly purified B cells did not respond to TPA, purified T cells proliferated to a similar degree as unseparated MNC; moreover, the addition of T to B lymphocytes enhanced proliferation rates proportionally to the number of T cells added. This suggests that TPA acts as a polyclonal T cell activator (PTA) for human blood and tonsil cells. Similarly, TPA induced only small amounts of Ig secretion in blood and in tonsil MNC, as determined by an ELISA assay, and no significant Ig secretion in highly purified B cells. The rather weak B cell differentiation response was not due to a monocyte suppressor effect, since partially monocyte-depleted MNC or B cells responded similarly to the non-depleted cells. Thus, TPA cannot be considered as an alternative to other B cells stimulators, both with regard to DNA synthesis and Ig secretion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878751      PMCID: PMC1577486     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Tumor promoter phorbol myristic acetate is a T-cell dependent inducer of immunoglobulin secretion in human lymphocytes.

Authors:  P Ralph; T Kishimoto
Journal:  Clin Immunol Immunopathol       Date:  1982-03

3.  Induction of differentiation in a case of common acute lymphoblastic leukemia.

Authors:  J Cossman; L M Neckers; A Arnold; S J Korsmeyer
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

4.  The immunoglobulin production of human peripheral B lymphocytes induced by phorbol myristate acetate.

Authors:  I Sugawara
Journal:  Cell Immunol       Date:  1982-09-01       Impact factor: 4.868

5.  Tumor promoter phorbol myristic acetate stimulates immunoglobulin secretion correlated with growth cessation in human B lymphocyte cell lines.

Authors:  P Ralph; T Kishimoto
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

6.  The degree of monocyte participation in human B- and T-cell activation by phorbol myristate acetate.

Authors:  I Sugawara; S Ishizaka
Journal:  Clin Immunol Immunopathol       Date:  1983-03

7.  Klebsiella pneumoniae stimulate highly purified human blood B cells to mature into plaque forming cells without prior proliferation.

Authors:  W L Gross; A Rucks
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

8.  Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells.

Authors:  T H Tötterman; K Nilsson; C Sundström
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

9.  [Streptococcal A-induced polyclonal T-cell activation leads to a secondary functional activation of human B-cells].

Authors:  W L Gross; M Schlaak
Journal:  Immun Infekt       Date:  1982-09

10.  Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes.

Authors:  A S Fauci; K R Pratt
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.